Silverberg Bernstein Capital Management’s AC Immune ACIU Stock Holding History

Silverberg Bernstein Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.8K	Hold	10,000	–	–	0.01%	69
2026 Q1	$27.5K	Hold	10,000	–	–	0.02%	68
2025 Q4	$31.3K	Hold	10,000	–	–	0.02%	66
2025 Q3	$28.9K	Hold	10,000	–	–	0.02%	67
2025 Q2	$20.3K	Hold	10,000	–	–	0.01%	67
2025 Q1	$18.7K	Hold	10,000	–	–	0.02%	62
2024 Q4	$27K	Hold	10,000	–	–	0.02%	54
2024 Q3	$37.8K	Hold	10,000	–	–	0.03%	52
2024 Q2	$39.9K	Buy	+10,000	New	+$33.1K	0.04%	52

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Silverberg Bernstein Capital Management's ACIU Position: Q2 2026 in Review

Silverberg Bernstein Capital Management held its AC Immune (ACIU) position steady in Q2 2026 at 10,000 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #69.

Silverberg Bernstein Capital Management first reported a position in ACIU in Q2 2024 and has held it in 9 quarters since. The position peaked at $39.9K in Q2 2024. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

Silverberg Bernstein Capital Management held 10,000 shares of AC Immune worth $23.8K as of Q2 2026.
Silverberg Bernstein Capital Management left its AC Immune share count unchanged in Q2 2026.
AC Immune made up 0.01% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #69 holding.
Silverberg Bernstein Capital Management first reported a position in AC Immune in Q2 2024 and has held it in 9 quarters since.
Silverberg Bernstein Capital Management's AC Immune position peaked at $39.9K in Q2 2024.
43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.